Cisplatin Selects for Multidrug-Resistant CD133+ Cells in Lung Adenocarcinoma by Activating Notch Signaling

Cancer Research - United States
doi 10.1158/0008-5472.can-12-1733
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Sox2 Inhibits WNT-Β-Catenin Signaling and Metastatic Potency of Cisplatin-Resistant Lung Adenocarcinoma Cells

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2017English

Β-Catenin Signaling Pathway Regulates Cisplatin Resistance in Lung Adenocarcinoma Cells by Upregulating BCL-Xl

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

MicroRNA‑134 Reverses Multidrug Resistance in Human Lung Adenocarcinoma Cells by Targeting FOXM1

Oncology Letters
Cancer ResearchOncology
2017English

miRNA-378 Reverses Chemoresistance to Cisplatin in Lung Adenocarcinoma Cells by Targeting Secreted Clusterin

Scientific Reports
Multidisciplinary
2016English

TAZ Inhibition Restores Sensitivity of Cisplatin via AKT/mTOR Signaling in Lung Adenocarcinoma

Oncology Reports
MedicineCancer ResearchOncology
2017English

Notch Signaling Inhibits Growth of the Human Lung Adenocarcinoma Cell Line A549

Oncology Reports
MedicineCancer ResearchOncology
2007English

RNF138 Confers Cisplatin Resistance in Gastric Cancer Cells via Activating Chk1 Signaling Pathway

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2018English

Lung Development and Notch Signaling

2020English

PUM1 Knockdown Prevents Tumor Progression by Activating the PERK/eIF2/ATF4 Signaling Pathway in Pancreatic Adenocarcinoma Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy